• Home >
  • Publications >
  • Chemosensitivity, tumor infiltrating lymphocytes (TILs), and survival of postpartum PABC patients treated by neoadjuvant chemotherapy

Chemosensitivity, tumor infiltrating lymphocytes (TILs), and survival of postpartum PABC patients treated by neoadjuvant chemotherapy

1 Dec 2018The Breast

DOI : 10.1016/j.breast.2018.08.103

Authors

Julie Labrosse, Inès Abdennebi, Lucie Thibault, Enora Laas, Hilde Merckelbagh, Charlotte Morel, Thanh Lam, Marick Lae, Fabien Reyal, Anne-Sophie Hamy